You have 9 free searches left this month | for more free features.

City

Busan (1)

Chengdu (1)

Masan (1)

Condition

Schizophrenia (2)

Bioequivalence (1)

Psychotic Disorders (1)

Overall Status

Unknown status (2)

Completed (1)

Sign in for free

Phase

phase 4 (2)

n/a (1)

Sponsor

Chengdu Kanghong Pharmaceutical Group Co., Ltd. (1)

Inje University (1)

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)

Collaborator

Janssen, LP (1)

Intervention

abilify (3)

bosiqing (1)

risperidal consta (1)

risperidne (1)

rispridoen and aripiprazole (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

abilify

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Bioequivalence Trial in Chengdu (Bosiqing, abilify)

Unknown status

Bioequivalence

Bosiqing
abilify

Chengdu, Sichuan, China

West China Hospital of Sichuan University

Jul 27, 2017

Schizophrenia, Psychotic Disorders Trial (Abilify, Risperidal Consta)

Completed

Has Results

Schizophrenia
Psychotic Disorders

Abilify
Risperidal Consta

(no location specified)

Dec 22, 2011

Schizophrenia Trial in Busan, Masan (Rispridoen and Aripiprazole, Risperidne, Abilify)

Unknown status

Schizophrenia

Rispridoen and Aripiprazole
+2 more

Busan, Korea, Republic of
+1 more

Aug 3, 2009